Hydroxyapatites

DBCAT006021Pharmacologic class

A group of compounds with the general formula M10(PO4)6(OH)2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. A DrugBank category of 1 drug. 1 of them is approved.

Drugs: Calcium Phosphate

What you can answer from here — as of October 21, 2025

1DrugEach linked to its full drug card

Listed above

33Drug targetsEvery drug–target pair in the class, with bond type

105Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Hydroxyapatites share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account